Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 AUD | -.--% | -.--% | -.--% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Development
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -92.24% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -92.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 04/01/23 | |
Director of Finance/CFO | 62 | 30/06/23 | |
Chief Tech/Sci/R&D Officer | - | 30/06/23 | |
Julie Kerner
COO | Chief Operating Officer | - | 30/06/23 |
Liz Doolin
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/12/07 |
Adrian Hinton
AUD | Comptroller/Controller/Auditor | 72 | 30/04/19 |
Rajeev Chandra
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Wilson
BRD | Director/Board Member | 61 | 15/06/16 |
Alan Fisher
CHM | Chairman | 71 | 31/08/16 |
Jane Ryan
BRD | Director/Board Member | 65 | 30/09/20 |
Aaron Weaver
BRD | Director/Board Member | 43 | 05/07/20 |
Chief Executive Officer | 52 | 04/01/23 | |
Peter Davies
BRD | Director/Board Member | 43 | 30/06/21 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.76% | 103B | |
+1.37% | 95.28B | |
+1.46% | 22.15B | |
-15.90% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.24% | 16.05B | |
+4.83% | 13.68B | |
+33.12% | 12.17B |
- Stock Market
- Equities
- BNOX Stock
- BNO Stock
- Company Bionomics